RAMSEY, N.J. (AP) _ Adma Biologics Inc. (ADMA) on Friday reported third-quarter net income of $15.2 million, after reporting a loss in the same period a year earlier.
The Ramsey, New Jersey-based company said it had net income of 59 cents per share.
The infectious disease drug developer posted revenue of $4.7 million in the period.
In the final minutes of trading on Friday, the company's shares hit $2.24. A year ago, they were trading at $5.07.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA